References
- Lumsden AB, Davies MG, Peden EK. Medical and endovascular management of critical limb ischemia. J Endovasc Ther 2009;16(2 Suppl 2):II:31-62.
- Aihara H, Soga Y, Mii S, Okazaki J, Yamaoka T, Kamoi D, et al.; RECANALISE Registry Investigators. Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease. Circ J 2014;78:457-464. https://doi.org/10.1253/circj.CJ-13-1147
- Soderstrom MI, Arvela EM, Korhonen M, Halmesmaki KH, Alback AN, Biancari F, et al. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis. Ann Surg 2010;252:765-773. https://doi.org/10.1097/SLA.0b013e3181fc3c73
- Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008;47:975-981. https://doi.org/10.1016/j.jvs.2008.01.005
- Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K, et al. Randomized comparison of everolimuseluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 2012;55:390-398. https://doi.org/10.1016/j.jvs.2011.07.099
- Scheinert D, Katsanos K, Zeller T, Koppensteiner R, Commeau P, Bosiers M, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol 2012;60:2290-2295. https://doi.org/10.1016/j.jacc.2012.08.989
- Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 2012;5:831-840. https://doi.org/10.1161/CIRCINTERVENTIONS.112.971630
- Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, et al. The LEVANT I (Lutonix paclitaxelcoated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv 2014;7:10-19. https://doi.org/10.1016/j.jcin.2013.05.022
- Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Braunlich S, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 2011;58:1105-1109. https://doi.org/10.1016/j.jacc.2011.05.034
- Liistro F, Porto I, Angioli P, Grotti S, Ricci L, Ducci K, et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 2013;128:615-621. https://doi.org/10.1161/CIRCULATIONAHA.113.001811
- Antoniou GA, Chalmers N, Georgiadis GS, Lazarides MK, Antoniou SA, Serracino-Inglott F, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 2013;57:242-253. https://doi.org/10.1016/j.jvs.2012.07.038
- Steiner S, Schmidt A, Bausback Y, Braunlich S, Ulr ich M, Banning-Eichenseer U, et al. Single-center experience with lutonix drug-coated balloons in infrapopliteal arteries. J Endovasc Ther 2016;23:417-423. https://doi.org/10.1177/1526602816645080
- Rosenf ield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al; LEVANT 2 Investigators. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 2015;373:145-153. https://doi.org/10.1056/NEJMoa1406235
- Giacoppo D, Cassese S, Harada Y, Colleran R, Michel J, Fusaro M, et al. Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and metaanalysis of randomized clinical trials. JACC Cardiovasc Interv 2016;9:1731-1742. https://doi.org/10.1016/j.jcin.2016.06.008
- Katsanos K, Spiliopoulos S, Karunanithy N, Krokidis M, Sabharwal T, Taylor P. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg 2014;59:1123-1133.e8. https://doi.org/10.1016/j.jvs.2014.01.041
- Thieme M, Von Bilderling P, Paetzel C, Karnabatidis D, Perez Delgado J, Lichtenberg M; Lutonix Global SFA Registry Investigators. The 24-month results of the lutonix global SFA registry: worldwide experience with lutonix drug-coated balloon. JACC Cardiovasc Interv 2017;10:1682-1690. https://doi.org/10.1016/j.jcin.2017.04.041
- Jang SJ, Hsieh CA, Huang HL, Juang JM, Chou HH, Tsao CY, et al. Feasibility and clinical outcomes of peripheral drug-coated balloon in high-risk patients with femoropopliteal disease. PLoS One 2015;10:e0143658. https://doi.org/10.1371/journal.pone.0143658
- Schmidt A, Piorkowski M, Gorner H, Steiner S, Bausback Y, Scheinert S, et al. Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry. JACC Cardiovasc Interv 2016;9:715-724.
- Garg K, Kaszubski PA, Moridzadeh R, Rockman CB, Adelman MA, Maldonado TS, et al. Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia. J Vasc Surg 2014;59:392-399. https://doi.org/10.1016/j.jvs.2013.09.001
- Vierthaler L, Callas PW, Goodney PP, Schanzer A, Patel VI, Cronenwett J, et al.; Vascular Study Group of New England. Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia. J Vasc Surg 2015;62:655-664. https://doi.org/10.1016/j.jvs.2015.04.391
- Zeller T, Beschorner U, Pilger E, Bosiers M, Deloose K, Peeters P, et al. Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK'S-First in man study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). JACC Cardiovasc Interv 2015;8:1614-1622. https://doi.org/10.1016/j.jcin.2015.07.011
- Wu R, Tang S, Wang M, Li Z, Yao C, Wang S. Drug-eluting balloon versus standard percutaneous transluminal angioplasty in infrapopliteal arterial disease: a meta-analysis of randomized trials. Int J Surg 2016;35:88-94. https://doi.org/10.1016/j.ijsu.2016.09.014
- Cassese S, Ndrepepa G, Liistro F, Fanelli F, Kufner S, Ott I, et al. Drugcoated balloons for revascularization of infrapopliteal arteries: a metaanalysis of randomized trials. JACC Cardiovasc Interv 2016;9:1072-1080. https://doi.org/10.1016/j.jcin.2016.02.011
- Westin GG, Armstrong EJ, Bang H, Yeo KK, Anderson D, Dawson DL, et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputationfree survival in patients with critical limb ischemia. J Am Coll Cardiol 2014;63:682-690. https://doi.org/10.1016/j.jacc.2013.09.073
- Varu VN, Hogg ME, Kibbe MR. Critical limb ischemia. J Vasc Surg 2010;51:230-241. https://doi.org/10.1016/j.jvs.2009.08.073
- Jalkanen J, Maksimow M, Hollmen M, Jalkanen S, Hakovirta H, et al. Compared to intermittant claudication critical limb ischemia is associated with elevated levels of cytokines. PLoS One 2016;11:e0162353. https://doi.org/10.1371/journal.pone.0162353
- Todoran TM, Connors G, Engelson BA, Sobieszczyk PS, Eisenhauer AC, Kinlay S. Femoral artery percutaneous revascularization for patients with critical limb ischemia: outcomes compared to patients with claudication over 2.5 years. Vasc Med 2012;17:138-144. https://doi.org/10.1177/1358863X12440141
- Trocciola SM, Chaer R, Dayal R, Lin SC, Kumar N, Rhee J, et al. Comparison of results in endovascular interventions for infrainguinal lesions: claudication versus critical limb ischemia. Am Surg 2005;71:474-479; discussion 480.
Cited by
- Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis vol.27, pp.4, 2018, https://doi.org/10.1177/1526602820931559